Qianhai Health Holdings Limited (HKG:0911)
Hong Kong · Delayed Price · Currency is HKD 0.5250
-0.0100 (-1.87%)
Aug 27, 2026, 4:08 PM HKT
Qianhai Health Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 91 | 47 | 48 | 63 | 149 | 127 | |
Market Cap Growth | 105.77% | -3.51% | -22.97% | -57.95% | 17.33% | -37.44% |
Enterprise Value | 73 | 20 | 46 | 54 | -14 | 140 |
Last Close Price | 0.54 | 0.28 | 0.28 | 0.37 | 0.88 | 0.75 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.61 | 7.84 | 36.84 | - | - | - |
PS Ratio | 0.20 | 0.07 | 0.09 | 0.07 | 0.08 | 0.45 |
PB Ratio | 0.23 | 0.12 | 0.13 | 0.16 | 0.34 | 0.19 |
P/TBV Ratio | 0.23 | 0.12 | 0.13 | 0.16 | 0.34 | 0.19 |
P/FCF Ratio | - | 1.22 | 11.52 | 73.16 | - | - |
P/OCF Ratio | - | 1.22 | 11.50 | 73.16 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.16 | 0.03 | 0.09 | 0.06 | - | 0.49 |
EV/EBITDA Ratio | 14.58 | 3.03 | 2.93 | - | - | - |
EV/EBIT Ratio | 18.80 | 3.51 | 3.29 | - | - | - |
EV/FCF Ratio | - | 0.52 | 10.92 | 63.25 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Debt / EBITDA Ratio | 0.02 | 0.06 | 0.06 | - | - | - |
Debt / FCF Ratio | - | 0.01 | 0.25 | 0.57 | - | - |
Net Debt / Equity Ratio | -0.05 | -0.16 | -0.06 | -0.05 | 0.00 | 0.01 |
Net Debt / EBITDA Ratio | -4.13 | -9.32 | -1.44 | 0.38 | 0.00 | -0.36 |
Net Debt / FCF Ratio | - | -1.60 | -5.36 | -22.41 | 0.12 | -0.12 |
Asset Turnover | 1.09 | 1.66 | 1.17 | 1.90 | 3.08 | 0.39 |
Inventory Turnover | 2.15 | 3.61 | 1.42 | 2.18 | 4.41 | 0.68 |
Quick Ratio | 2.96 | 16.54 | 5.74 | 0.21 | 0.05 | 2.90 |
Current Ratio | 8.92 | 22.62 | 18.12 | 4.81 | 5.20 | 10.14 |
Return on Equity (ROE) | 1.02% | 1.53% | 0.34% | -12.84% | -42.21% | -0.13% |
Return on Assets (ROA) | 0.58% | 0.87% | 1.97% | -6.44% | -16.10% | -1.36% |
Return on Invested Capital (ROIC) | 1.01% | 1.64% | 3.82% | -13.03% | -29.49% | -2.37% |
Return on Capital Employed (ROCE) | 1.00% | 1.40% | 3.60% | -13.60% | -37.50% | -2.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.42% | 12.75% | 2.71% | -84.07% | -156.73% | -0.70% |
FCF Yield | - | 82.19% | 8.68% | 1.37% | -3.53% | -34.77% |
Buyback Yield / Dilution | - | - | - | - | -0.08% | -0.01% |
Total Shareholder Return | - | - | - | - | -0.08% | -0.01% |